News & Press Releases

This Law360 Expert Analysis column, authored by Mintz Member Peter Saparoff and Associate Joel Rothman, discusses several recent developments which highlight why foreign securities litigation is an ever-changing scenario where nothing is definite.

This feature article discusses the top FDA-related issues that the medical device industry is keeping an eye on for the 2019 year. Among those top concerns are new regulations involving laboratory developed tests (LDTs), digital health apps and medical device cybersecurity, among others. Aaron Josephson, senior director at ML Strategies and a former senior policy advisor at FDA’s device center, is among the industry sources quoted.

This article in The Boston Globe looks at how a law – signed in August and which took effect in November – is impacting Boston’s start-up community. The specific law is the Committee on Foreign Investment in the United States (CFIUS) and it requires foreign entities investing in U.S. companies in 27 “critical” industries to be properly documented with CFIUS at the risk of penalties.

This feature article takes an in-depth look at how law firms and their leadership teams are taking a look at their approach to origination credit. Mintz Managing Member Bob Bodian is prominently featured throughout the article. In the piece, Bob discusses creating goals for a new approach – fostering teamwork, putting clients first and affording younger attorneys the ability to take more ownership – and launching the new system back in 2015.